Quarter
Charts

LIFEVANTAGE CORP

LFVN

CIK 0000849146 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$49M
↓-27.8% -$19Mvs FY2024 (Q4)
Operating Income
$487K
↓-85.8% -$3Mvs FY2024 (Q4)
Net Income
$276K
↓-89.2% -$2Mvs FY2024 (Q4)
Gross Profit
$36M
↓-33.6% -$18Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
68/100
  • Profitability
    100ROIC 32.2% (10% = solid, 20%+ = moat)
  • Liquidity
    68Current Ratio 1.87 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    100Asset Turnover 3.46x (1.0+ = capital-efficient)
  • Growth
    0Revenue YoY -27.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    38Op Margin 1.0% · trend -0.7pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project LFVN's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

18%

Trailing 3-yr CAGR was 17.8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$20.72
Total enterprise IV
$269M
Diluted shares
0.01B
Terminal PV
$204M (76% of total)
Year-5 FCF
$24M
YearProjected FCFDiscounted PV
+1$12M$11M
+2$15M$12M
+3$17M$13M
+4$20M$14M
+5$24M$15M
Terminal$329M$204M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$2M
investment in PP&E
Dividends paid (TTM)
$2M
cash returned to holders
Stock buybacks (TTM)
$3M
share count reduction
Stock-based comp (TTM)
$4M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$61M
everything owned
Total liabilities
$28M
everything owed
Stockholders' equity
$33M
shareholder claim
Net debt
$-20M
Net cash position ($20M)

Recent performance · 62 quarters

Revenue↓-27.8% -$19M
$49M
Net Income↓-89.2% -$2M
$276K
Free Cash Flow↓-80.4% -$7M
$2M
Operating Margin↓-4.1pts
1.0%

Drill down

LFVN Sankey

See LIFEVANTAGE CORP's revenue flow into every line item of the income statement and balance sheet — every dollar accounted for, with prior-period comparison.

Open Sankey

LFVN Charts

62 quarters of historical line items — Income, Cash Flow, Balance Sheet, plus margins. Click any chart for the trend dialog.

Open Charts

LFVN Key Metrics

EPS, BVPS, FCF/Share, ROE, ROA, ROIC, D/E, Current Ratio, Quick Ratio, Asset Turnover — 10 CFA-grade fundamentals derived from EDGAR data.

Open Key Metrics